Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by Snowdrifton Jun 05, 2023 9:42am
147 Views
Post# 35480160

What a great presentation!

What a great presentation!I really loved this presentation!

The previous KOL presentation I had watched was so boring and antiseptic and tepid.

This presentation was interesting, easy to understand for lay folks like myself, and you could feel the enthusiasm.

I especially appreciated Dr. Picard's comments.  She had a very human viewpoint.  She really cares about the patients and their quality of life.  I loved that she made a special point of saying that the Phase 3 study should make sure to treat side effects ASAP.

And of course, it was fabulous to hear Matt Coffee say that Oncolytics has been talking with many BPs and there's a lot of interest.

All very promising !! 
<< Previous
Bullboard Posts
Next >>